SCHEMBL23047323

SCHEMBL23047323

Nc1ncnc2c1c(-c1ccc(OCCN3CCOCC3)cc1)nn2-c1ccc(NC=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 6/20 0.65
▸ LCK P06239 5/20 0.65
▸ CSF1R P07333 1/20 0.65
▸ RET P07949 1/20 0.65
▸ PDGFRB P09619 1/20 0.65
▸ KIT P10721 1/20 0.65
▸ PDGFRA P16234 1/20 0.65
▸ CDK11B P21127 1/20 0.65
▸ CCNC P24863 1/20 0.65
▸ FLT4 P35916 1/20 0.65
▸ FLT3 P36888 1/20 0.65
▸ CDK8 P49336 1/20 0.65
▸ DDR1 Q08345 1/20 0.65
▸ DDR2 Q16832 1/20 0.65
▸ MKNK2 Q9HBH9 1/20 0.65
▸ ADORA2A P29274 1/20 0.46
▸ ADORA1 P30542 1/20 0.46
▸ METTL3 Q86U44 1/20 0.45
▸ TNK2 Q07912 1/20 0.43
▸ EGFR P00533 6/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19683613 0.88 BTK (0.63) BTKLCKCSF1RRETPDGFRB
SCHEMBL19683609 0.84 LCK (0.60) BTKLCKCSF1RRETPDGFRB
SCHEMBL19683819 0.83 FLT3 (0.81) BTKLCKCSF1RRETPDGFRB
SCHEMBL19683590 0.83 FLT3 (0.72) BTKLCKCSF1RRETPDGFRB
SCHEMBL19683779 0.82 FLT3 (0.77) BTKLCKCSF1RRETPDGFRB
SCHEMBL19683815 0.81 LCK (0.64) BTKLCKCSF1RRETPDGFRB
SCHEMBL20873189 0.81 FLT3 (0.70) BTKLCKCSF1RRETPDGFRB
SCHEMBL19683700 0.81 FLT3 (0.48) BTKLCKCSF1RRETPDGFRB
SCHEMBL19683823 0.81 FLT3 (0.73) BTKLCKCSF1RRETPDGFRB
SCHEMBL19683607 0.81 RET (0.84) BTKLCKCSF1RRETPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3466952-B1 1-(4-(4-AMINO-3-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)-PHENYL)-UREA DERIVATIVES AS FLT3 KINASE INHIBITORS FOR TREATING CANCER PRECEDO PHARMACEUTICALS CO LTD (CN) 2021-03-03 — — EP disclosed
Send feedback